A New York federal judge has granted final approval of a $400 million settlement that ends a class action accusing Pfizer Inc. of misleading investors about illegal off-label drug marketing.... Read more
Pfizer Inc. reached a $400 million settlement in a class action brought by its investors flowing from the company’s off-label drug marketing scheme. The class action stemmed from a comprehen... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.